Perspective Therapeutics Inc

NYSE American: CATX    
Share price (4/25/24): $1.60    
Market cap (4/25/24): $939 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 3 pages Amendment No. 1 to Asset Purchase Agreement
12/34/56
EX-2.1
from 8-K 96 pages Asset Purchase Agreement by and Between Isoray Medical, Inc. as Seller, Perspective Therapeutics, Inc. as Seller Parent and Gt Medical Technologies, Inc. as Buyer Dated as of December 7, 2023
12/34/56
EX-2.1
from DEFA14A 3 pages First Amendment to Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 3 pages First Amendment to Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 138 pages Agreement and Plan of Merger Dated September 27, 2022 by and Among Isoray, Inc., a Delaware Corporation as the Acquirer, Isoray Acquisition Corp., a Delaware Corporation as Merger Sub, Viewpoint Molecular Targeting, Inc., a Delaware Corporation as the Target Company, and Cameron Gray as the Owners’ Representative
12/34/56
EX-2.1
from DEFA14A 138 pages Agreement and Plan of Merger Dated September 27, 2022 by and Among Isoray, Inc., a Delaware Corporation as the Acquirer, Isoray Acquisition Corp., a Delaware Corporation as Merger Sub, Viewpoint Molecular Targeting, Inc., a Delaware Corporation as the Target Company, and Cameron Gray as the Owners’ Representative
12/34/56
EX-2
from 8-A12G 7 pages Certificate of Designation of Rights, Preferences and Privileges of Series C Junior Participating Preferred Stock of Isoray, Inc
12/34/56
EX-2.2
from 8-K 7 pages Certificate of Merger Merging Century Park Transitory Subsidiary, Inc. Into Isoray Medical, Inc
12/34/56
EX-2.1
from 8-K 54 pages Merger Agreement Among Century Park Pictures Corporation, Century Park Transitory Subsidiary, Inc., Certain Shareholders, and Isoray Medical, Inc. May 27, 2005
12/34/56